Dr Ulmert and Dr Evans talk with ecancertv at the AACR 2012 Annual Meeting about prostate specific antigens (PSA) and radiotracers for patients with prostate cancer, specifically castration resistant prostate cancer.

Dr Evans explains the how partnership between him and Dr Ulmert will hopefully result in developing non-invasive biomarkers, uncovering onco-genic signaling pathways, and using radiotracers to stage treatment response.